PillRx only · Injection, Solution · Intramuscular
Palivizumab
Brands: Synagis · Palivizumab
0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
122
Rx · 2025 Q4
99
Units dispensed
4
Quarters · since 2025 Q1
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Swedish Orphan Biovitrum AB (publ) | unknown | 2 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Aug 13, 2025RESOLVEDShortage resolved: Palivizumab Injection (Swedish Orphan Biovitrum AB)
Palivizumab Injection — reported in shortage by Swedish Orphan Biovitrum AB. Therapeutic category: Antiviral.
- Aug 13, 2025SHORTAGEDrug shortage: Palivizumab Injection (Swedish Orphan Biovitrum AB)
Palivizumab Injection — reported in shortage by Swedish Orphan Biovitrum AB. Therapeutic category: Antiviral.